Food-tech disruptor prepares to vastly scale dairy-identical, non-animal milk protein production in a pioneering sustainable industrial park in Denmark
Following the close of $120 million in Series B funding, Remilk, the food-tech innovator reimagining dairy, announced it will build a full-scale precision fermentation facility on more than 750,000sq-ft of newly acquired land within The Symbiosis project, a pioneering sustainable industrial ecosystem, in Kalundborg, Denmark. This next major milestone demonstrates Remilk's continued leadership in the rapidly developing category by offering consumers animal-free dairy products identical to its traditional counterparts but free of lactose, cholesterol, and hormones, thus severing the dairy supply chain's reliance on animals.
Kalundborg's Symbiosis project is a pioneering industrial ecosystem with transformational economic and environmental results. Within the network, byproducts of one company become resources for another. At present, Symbiosis is a collaborative effort involving more than a dozen visionary public and private companies including industry giants such as Novozymes, Novo Nordisk and Chr. Hansen. At the new facility, Remilk will produce non-animal dairy protein for use in products like cheese, yogurt, and ice cream, in volumes equivalent to that produced by 50,000 cows each year.